Genscript Biotech Corporation (1548.HK)

HKD 11.18

(2.38%)

Net Income Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual net income in 2023 was -95.47 Million USD , up 57.91% from previous year.
Genscript Biotech Corporation's latest quarterly net income in 2024 Q2 was -175.11 Million USD , down -9136.02% from previous quarter.
Genscript Biotech Corporation reported an annual net income of -226.85 Million USD in 2022, up 36.76% from previous year.
Genscript Biotech Corporation reported an annual net income of -358.71 Million USD in 2021, down -75.03% from previous year.
Genscript Biotech Corporation reported a quarterly net income of -93.58 Million USD for 2023 Q2, down -2.45% from previous quarter.
Genscript Biotech Corporation reported a quarterly net income of -1.89 Million USD for 2023 Q4, up 97.97% from previous quarter.

Annual Net Income Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Net Income of Genscript Biotech Corporation (2023 - 2013)

Year	Net Income	Net Income Growth
2023	-95.47 Million USD	57.91%
2022	-226.85 Million USD	36.76%
2021	-358.71 Million USD	-75.03%
2020	-204.94 Million USD	-111.48%
2019	-96.91 Million USD	-556.79%
2018	21.21 Million USD	-18.78%
2017	26.12 Million USD	-0.18%
2016	26.17 Million USD	49.51%
2015	17.5 Million USD	183.47%
2014	6.17 Million USD	2.92%
2013	6 Million USD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-175.11 Million USD	-9136.02%
2023 Q2	-93.58 Million USD	-2.45%
2023 Q4	-1.89 Million USD	97.97%
2023 FY	-95.47 Million USD	57.91%
2022 FY	-226.85 Million USD	36.76%
2022 Q4	-91.34 Million USD	32.59%
2022 Q2	-135.5 Million USD	49.36%
2021 FY	-358.71 Million USD	-75.03%
2021 Q4	-267.58 Million USD	-193.66%
2021 Q2	-91.12 Million USD	0.8%
2020 Q2	-113.09 Million USD	-62.57%
2020 FY	-204.94 Million USD	-111.48%
2020 Q4	-91.85 Million USD	18.78%
2019 FY	-96.91 Million USD	-556.79%
2019 Q4	-69.56 Million USD	-154.39%
2019 Q2	-27.34 Million USD	-580.01%
2018 Q4	5.69 Million USD	-63.29%
2018 Q2	15.51 Million USD	39.27%
2018 FY	21.21 Million USD	-18.78%
2017 Q4	11.14 Million USD	-25.61%
2017 FY	26.12 Million USD	-0.18%
2017 Q2	14.98 Million USD	15.42%
2016 Q2	13.19 Million USD	12.19%
2016 Q4	12.97 Million USD	-1.61%
2016 FY	26.17 Million USD	49.51%
2015 Q4	11.75 Million USD	104.63%
2015 Q2	5.74 Million USD	169.89%
2015 FY	17.5 Million USD	183.47%
2014 Q4	2.12 Million USD	-47.38%
2014 Q2	4.04 Million USD	162.09%
2014 FY	6.17 Million USD	2.92%
2013 Q4	1.54 Million USD	0.0%
2013 FY	6 Million USD	0.0%

Peer Net Income Comparison of Genscript Biotech Corporation

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	234.71%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	653.49%